Mitrix gains funding to transfuse young mitochondria
Longevity Technology - 28-Jan-2021Trials on mitochondrial transfusion might help tackle many ageing diseases
Join the club for FREE to access the whole archive and other member benefits.
Managing Director and Founder at R42 Group.
Dr. Ronjon Nag is an inventor, entrepreneur and a Stanford Distinguished Careers Institute Interdisciplinary Fellow based at the Stanford Center for Language and Information (CSLI). He is a founder and advisor/board member of multiple start-ups. His companies have been sold to Apple, BlackBerry, and Motorola. He has been awarded the Mountbatten Medal in the Royal Institution by the Institution of Engineering and Technology, and has been winner (Bounce Imaging-Board) of the $1m Verizon Powerful Answers Award.He has been a pioneer of smartphones and the 'app stores' they depend on. He has worked on neural networks, touch screens, mobile search, voice recognition, text prediction and handwriting recognition.
He has a Ph.D from Cambridge, an M.S from M.I.T and a B.Sc. from Birmingham in the UK.
Visit website: https://www.r42group.com/dr-ronjon-nag
See also: R42 Group - Company Inventing and Investing in AI, Science and Biotech.
Details last updated 09-Apr-2020
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
04-May-2021 to 07-May-2021
The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).
26-Feb-2022 to 27-Feb-2022
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
03-Dec-2024 to 04-Dec-2024
Longevity researchers, investors, and entrepreneurs speaking about eliminating disease of ageing by Longevity Global (Novato, CA, USA)
Trials on mitochondrial transfusion might help tackle many ageing diseases
Funding targets early-stage companies and postdoc researchers with unique ideas